Registry analysis suggests women often receive too much treatment with glycoprotein 2B3A inhibitors. Duke University’s Karen Alexander told us more. [audio:https://www.audiomedica.com/podcasting
Registry analysis suggests women often receive too much treatment with glycoprotein 2B3A inhibitors. Duke University’sKaren Alexandertold us more.